BioCentury
ARTICLE | Clinical News

Oncaspar pegaspargase regulatory update

January 25, 2016 8:00 AM UTC

The European Commission approved an MAA from Baxalta for Oncaspar pegaspargase to treat acute lymphoblastic leukemia (ALL) in patients of all ages in combination with antineoplastic therapy. In Novemb...